Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
35
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
13 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Mitek Systems
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Regulatory Shifts Will Undermine Legacy Digital Identity Markets
Key Takeaways Heightened regulatory pressures, disruptive digital identity technologies, and growing competition threaten Mitek's revenue, margins, and core market relevance. Heavy reliance on legacy banking sectors and lagging innovation expose the company to sharp declines in recurring revenue and long-term market share losses.
View narrative
US$10.00
FV
5.5% overvalued
intrinsic discount
5.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Senior
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Geopolitical Tensions And Supply Disruptions Will Undermine Aerospace Outlook
Key Takeaways Tightening decarbonization goals and manufacturing innovations threaten long-term market share, revenue, and margin growth in Senior's core aerospace segments. Persistent supply chain fragility and exposure to legacy aerospace platforms increase operational risks and undermine earnings quality amid evolving industry dynamics.
View narrative
UK£1.85
FV
8.4% overvalued
intrinsic discount
-7.86%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Alkyl Amines Chemicals
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Persistent Oversupply And Strict Regulations Will Burden Future Performance
Key Takeaways Persistent oversupply, rising competition, and volatile input costs are depressing margins and limiting revenue growth prospects for Alkyl Amines. Costly upgrades for environmental compliance and declining export opportunities are further straining profitability and earnings stability.
View narrative
₹2.03k
FV
4.4% overvalued
intrinsic discount
22.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
SmartRent
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
SaaS Transformation And AI Will Secure Future Resilience
Key Takeaways Transition to a SaaS model and AI-driven platform enhancements are boosting recurring high-margin revenue, supporting sustainable earnings growth and top-line expansion. Strong customer retention and a growing installed base create a powerful network effect, providing operating leverage and positioning for future profitability and ecosystem growth.
View narrative
US$1.48
FV
0.3% overvalued
intrinsic discount
13.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
11 days ago
author updated this narrative
Alembic Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Regulatory Scrutiny And Supply Issues Will Squeeze Pharma Prospects
Key Takeaways Increased regulatory, compliance, and geopolitical pressures risk inflating costs, delaying launches, and destabilizing Alembic's overseas revenue streams. Heavy US market dependence and lag in biologics threaten market share, margins, and future earnings amid industry shifts and intensifying competition.
View narrative
₹900.00
FV
8.7% overvalued
intrinsic discount
9.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Tokyu
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Shibuya Redevelopment Will Struggle As Urban Demand Falls
Key Takeaways Demographic shifts, suburbanization, and new mobility trends are set to erode core demand, undermining Tokyu's revenue growth and diversification strategies. High capital and labor costs, along with regional concentration, risk compressing margins and diminishing profitability if market conditions deteriorate.
View narrative
JP¥1.80k
FV
5.1% overvalued
intrinsic discount
2.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Nedbank Group
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Legacy IT And Rising Regulatory Burdens Will Weigh On Prospects
Key Takeaways Weak digital transformation and legacy IT systems risk accelerating customer attrition and diminish Nedbank's relevance amid aggressive fintech competition. Heavy reliance on a challenging domestic market and rising regulatory costs threaten profitability and heighten exposure to demographic and economic headwinds.
View narrative
R239.00
FV
2.4% undervalued
intrinsic discount
9.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
3034
Novatek Microelectronics
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Chinese Subsidies And Tech Shifts Will Shrink Addressable Markets
Key Takeaways Slowing demand growth and rising competition threaten Novatek's top-line performance and could compress margins in key segments. Advanced technology shifts and stricter global regulations risk eroding core market relevance and driving up operational costs.
View narrative
NT$400.00
FV
6.5% overvalued
intrinsic discount
0.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Alinma Bank
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Saudi Banking Competition And Rising Costs Will Squeeze Margins
Key Takeaways Intensifying competition and digital disruption are compressing margins and threatening Alinma's traditional customer base and revenue streams. High operating expenses and regulatory pressures risk eroding profitability and hindering sustainable long-term growth.
View narrative
ر.س26.70
FV
2.8% undervalued
intrinsic discount
10.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
15 days ago
author updated this narrative
Value any company in seconds
Popular companies